Figure 3 shows that the expression levels of five proteins were significantly changed in AD samples vs. controls, among which GSN and TIMP1were increased in AD samples, while BDNF, VLDLR and APLP2 were decreased. Here, APLP2 is linked to Alzheimer disease.